Evidence for a novel osteosarcoma tumor-suppressor gene in the chromosome 18 region genetically linked with Paget disease of bone

Maggie J. Nellissery, Susan S. Padalecki, Zoran Brkanac, Frederick R. Singer, G. David Roodman, K. Krishnan Unni, Robin J. Leach, Marc F. Hansen

Research output: Contribution to journalArticle

79 Citations (Scopus)

Abstract

Paget disease of bone, or 'osteitis deformans', is a bone disorder characterized by rapid bone remodeling resulting in abnormal bone formation. It is the second most common metabolic bone disease after osteoporosis, affecting 3%-5% of subjects aged >40 years. Recent evidence suggests that predisposition to Paget disease may have a genetic component. Genetic linkage analysis of families with multigenerational Paget disease shows linkage to a region of chromosome 18q near the polymorphic locus D18S42. Approximately 1% of Paget patients develop osteosarcoma, which represents an increase in risk that is several thousandfold over that of the general population. Osteosarcoma in Paget patients is the underlying basis for a significant fraction of osteosarcomas occurring after age 60 years. Our analysis of tumor-specific loss of constitutional heterozygosity (LOH) in 96 sporadic osteosarcomas has identified a putative tumor-suppressor locus that maps to chromosome 18q. We have localized this tumor-suppressor locus between D18S60 and D18S42, a region tightly linked to familial Paget disease. Analysis of osteosarcomas from patients with Paget disease revealed that these tumors also undergo LOH in this region. These findings suggest that the association between Paget disease and osteosarcoma is the result of a single gene or two tightly linked genes on chromosome 18.

Original languageEnglish (US)
Pages (from-to)817-824
Number of pages8
JournalAmerican Journal of Human Genetics
Volume63
Issue number3
DOIs
StatePublished - Sep 1998
Externally publishedYes

Fingerprint

Osteitis Deformans
Chromosomes, Human, Pair 18
Osteosarcoma
Tumor Suppressor Genes
Loss of Heterozygosity
Neoplasms
Chromosomes
Genetic Linkage
Bone Remodeling
Metabolic Bone Diseases
Osteogenesis
Genes
Osteoporosis
Bone and Bones
Population

ASJC Scopus subject areas

  • Genetics

Cite this

Evidence for a novel osteosarcoma tumor-suppressor gene in the chromosome 18 region genetically linked with Paget disease of bone. / Nellissery, Maggie J.; Padalecki, Susan S.; Brkanac, Zoran; Singer, Frederick R.; Roodman, G. David; Unni, K. Krishnan; Leach, Robin J.; Hansen, Marc F.

In: American Journal of Human Genetics, Vol. 63, No. 3, 09.1998, p. 817-824.

Research output: Contribution to journalArticle

Nellissery, Maggie J. ; Padalecki, Susan S. ; Brkanac, Zoran ; Singer, Frederick R. ; Roodman, G. David ; Unni, K. Krishnan ; Leach, Robin J. ; Hansen, Marc F. / Evidence for a novel osteosarcoma tumor-suppressor gene in the chromosome 18 region genetically linked with Paget disease of bone. In: American Journal of Human Genetics. 1998 ; Vol. 63, No. 3. pp. 817-824.
@article{ecc3f0fc3c98406ca2f1bd1f51f9ead4,
title = "Evidence for a novel osteosarcoma tumor-suppressor gene in the chromosome 18 region genetically linked with Paget disease of bone",
abstract = "Paget disease of bone, or 'osteitis deformans', is a bone disorder characterized by rapid bone remodeling resulting in abnormal bone formation. It is the second most common metabolic bone disease after osteoporosis, affecting 3{\%}-5{\%} of subjects aged >40 years. Recent evidence suggests that predisposition to Paget disease may have a genetic component. Genetic linkage analysis of families with multigenerational Paget disease shows linkage to a region of chromosome 18q near the polymorphic locus D18S42. Approximately 1{\%} of Paget patients develop osteosarcoma, which represents an increase in risk that is several thousandfold over that of the general population. Osteosarcoma in Paget patients is the underlying basis for a significant fraction of osteosarcomas occurring after age 60 years. Our analysis of tumor-specific loss of constitutional heterozygosity (LOH) in 96 sporadic osteosarcomas has identified a putative tumor-suppressor locus that maps to chromosome 18q. We have localized this tumor-suppressor locus between D18S60 and D18S42, a region tightly linked to familial Paget disease. Analysis of osteosarcomas from patients with Paget disease revealed that these tumors also undergo LOH in this region. These findings suggest that the association between Paget disease and osteosarcoma is the result of a single gene or two tightly linked genes on chromosome 18.",
author = "Nellissery, {Maggie J.} and Padalecki, {Susan S.} and Zoran Brkanac and Singer, {Frederick R.} and Roodman, {G. David} and Unni, {K. Krishnan} and Leach, {Robin J.} and Hansen, {Marc F.}",
year = "1998",
month = "9",
doi = "10.1086/302019",
language = "English (US)",
volume = "63",
pages = "817--824",
journal = "American Journal of Human Genetics",
issn = "0002-9297",
publisher = "Cell Press",
number = "3",

}

TY - JOUR

T1 - Evidence for a novel osteosarcoma tumor-suppressor gene in the chromosome 18 region genetically linked with Paget disease of bone

AU - Nellissery, Maggie J.

AU - Padalecki, Susan S.

AU - Brkanac, Zoran

AU - Singer, Frederick R.

AU - Roodman, G. David

AU - Unni, K. Krishnan

AU - Leach, Robin J.

AU - Hansen, Marc F.

PY - 1998/9

Y1 - 1998/9

N2 - Paget disease of bone, or 'osteitis deformans', is a bone disorder characterized by rapid bone remodeling resulting in abnormal bone formation. It is the second most common metabolic bone disease after osteoporosis, affecting 3%-5% of subjects aged >40 years. Recent evidence suggests that predisposition to Paget disease may have a genetic component. Genetic linkage analysis of families with multigenerational Paget disease shows linkage to a region of chromosome 18q near the polymorphic locus D18S42. Approximately 1% of Paget patients develop osteosarcoma, which represents an increase in risk that is several thousandfold over that of the general population. Osteosarcoma in Paget patients is the underlying basis for a significant fraction of osteosarcomas occurring after age 60 years. Our analysis of tumor-specific loss of constitutional heterozygosity (LOH) in 96 sporadic osteosarcomas has identified a putative tumor-suppressor locus that maps to chromosome 18q. We have localized this tumor-suppressor locus between D18S60 and D18S42, a region tightly linked to familial Paget disease. Analysis of osteosarcomas from patients with Paget disease revealed that these tumors also undergo LOH in this region. These findings suggest that the association between Paget disease and osteosarcoma is the result of a single gene or two tightly linked genes on chromosome 18.

AB - Paget disease of bone, or 'osteitis deformans', is a bone disorder characterized by rapid bone remodeling resulting in abnormal bone formation. It is the second most common metabolic bone disease after osteoporosis, affecting 3%-5% of subjects aged >40 years. Recent evidence suggests that predisposition to Paget disease may have a genetic component. Genetic linkage analysis of families with multigenerational Paget disease shows linkage to a region of chromosome 18q near the polymorphic locus D18S42. Approximately 1% of Paget patients develop osteosarcoma, which represents an increase in risk that is several thousandfold over that of the general population. Osteosarcoma in Paget patients is the underlying basis for a significant fraction of osteosarcomas occurring after age 60 years. Our analysis of tumor-specific loss of constitutional heterozygosity (LOH) in 96 sporadic osteosarcomas has identified a putative tumor-suppressor locus that maps to chromosome 18q. We have localized this tumor-suppressor locus between D18S60 and D18S42, a region tightly linked to familial Paget disease. Analysis of osteosarcomas from patients with Paget disease revealed that these tumors also undergo LOH in this region. These findings suggest that the association between Paget disease and osteosarcoma is the result of a single gene or two tightly linked genes on chromosome 18.

UR - http://www.scopus.com/inward/record.url?scp=0032231715&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032231715&partnerID=8YFLogxK

U2 - 10.1086/302019

DO - 10.1086/302019

M3 - Article

C2 - 9718349

AN - SCOPUS:0032231715

VL - 63

SP - 817

EP - 824

JO - American Journal of Human Genetics

JF - American Journal of Human Genetics

SN - 0002-9297

IS - 3

ER -